MAP1LC3A and non-small cell lung carcinoma: As shown in Figure 5a–f, AS-IV (5 ng/mL) group and propofol (2.5 μg/mL) group significantly reduced LC3, Beclin 1, ATG5, and p-ERK/ERK levels in NSCLC cells.